IFT57 and central nervous system cancer: Notably, IFT57 mRNA higher than the mean was significantly correlated with decreased overall survival in low-grade glioma (55 versus 93 months, logrank p-value = 2.7 × 10−4) and in lung squamous carcinoma (39 versus 64 months, logrank p-value = 9.9 × 10−3 Table 1, Figure 2b,d).